MASI 📈 Masimo - Overview

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US5747951003

MASI: Pulse Oximeters, Patient Monitors, Automation Solutions, Connectivity Platforms

Masimo Corporation is a global leader in the development, manufacturing, and marketing of innovative patient monitoring technologies, as well as automation and connectivity solutions. The company's product portfolio includes a range of technologies designed to improve patient outcomes, such as Masimo Signal Extraction Technology (SET) pulse oximetry, which provides accurate monitoring of oxygen saturation and pulse rate even in challenging conditions like motion or low perfusion. This technology has been shown to address the primary limitations of conventional pulse oximetry, providing healthcare professionals with more reliable and accurate data to inform their decisions.

The Masimo Rainbow SET platform is another key offering from the company, providing noninvasive monitoring of various parameters such as carboxyhemoglobin, methemoglobin, and hemoglobin concentration. This platform also enables the measurement of fractional arterial oxygen saturation, oxygen content, and pleth variability index, among other parameters. Additionally, the company offers acoustic respiration monitoring, SedLine brain function monitoring, and NomoLine capnography and gas monitoring, as well as regional oximetry solutions. These technologies are designed to provide healthcare professionals with a more comprehensive understanding of their patients' conditions, enabling them to make more informed decisions and improve patient outcomes.

Masimo Corporation also provides a range of brain function and hemodynamic monitoring solutions, including patient position and activity tracking, and neuromodulation technology solutions. The company's Masimo Hospital Automation platform offers a suite of hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, and SafetyNet, among others. These solutions are designed to help healthcare providers streamline their workflows, reduce errors, and improve patient safety. The company also offers nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions, further expanding its portfolio of innovative healthcare technologies.

In terms of its business model, Masimo Corporation sells its products through a combination of direct sales force, distributors, and original equipment manufacturer partners. The company's products are used by a range of healthcare providers, including hospitals, emergency medical services, home care providers, long-term care facilities, physician offices, veterinarians, and consumers. The company also offers home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. With a strong presence in the global healthcare market, Masimo Corporation is well-positioned to continue innovating and expanding its portfolio of patient monitoring technologies and automation solutions.

Founded in 1989 and headquartered in Irvine, California, Masimo Corporation has established itself as a leading player in the healthcare technology industry. With a web presence at https://www.masimo.com, the company provides easy access to information about its products and services. As a publicly traded company listed on the NASDAQ stock exchange under the ticker symbol MASI, Masimo Corporation is committed to transparency and accountability in its operations. With an ISIN of US5747951003 and a classification as a common stock in the Health Care Equipment sub-industry, the company is well-positioned for continued growth and success in the years to come.

Additional Sources for MASI Stock

MASI Stock Overview

Market Cap in USD 9,238m
Sector Healthcare
Industry Medical Devices
GiC Sub-Industry Health Care Equipment
IPO / Inception 2007-08-08

MASI Stock Ratings

Growth 5y -13.7%
Fundamental 10.5%
Dividend 0.30%
Rel. Strength Industry 853
Analysts 4/5
Fair Price Momentum 174.10 USD
Fair Price DCF 72.29 USD

MASI Dividends

Dividend Yield 12m 0.00%
Yield on Cost 5y %
Annual Growth 5y 0.00%
Payout Consistency 1.0%

MASI Growth Ratios

Growth Correlation 3m 93.1%
Growth Correlation 12m 34.4%
Growth Correlation 5y -70.2%
CAGR 5y 1.25%
CAGR/Mean DD 5y 0.04
Sharpe Ratio 12m 1.03
Alpha 19.96
Beta 0.89
Volatility 30.78%
Current Volume 1105.2k
Average Volume 20d 538k
What is the price of MASI stocks?
As of December 21, 2024, the stock is trading at USD 169.52 with a total of 1,105,213 shares traded.
Over the past week, the price has changed by -3.76%, over one month by +2.77%, over three months by +39.61% and over the past year by +49.04%.
Is Masimo a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Masimo is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 10.48 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MASI as of December 2024 is 174.10. This means that MASI is currently overvalued and has a potential downside of 2.7%.
Is MASI a buy, sell or hold?
Masimo has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy MASI.
  • Strong Buy: 4
  • Buy: 2
  • Hold: 4
  • Sell: 0
  • Strong Sell: 0
What are the forecast for MASI stock price target?
According to ValueRays Forecast Model, MASI Masimo will be worth about 192.1 in December 2025. The stock is currently trading at 169.52. This means that the stock has a potential upside of +13.29%.
Issuer Forecast Upside
Wallstreet Target Price 169 -0.3%
Analysts Target Price 130.6 -22.9%
ValueRay Target Price 192.1 13.3%